Navigation Links
FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
Date:10/16/2009

e days in 4.4% of patients treated with oral allopurinol alone and 6.5% of patients treated with the Elitek/oral allopurinol combination, versus 0% of patients receiving Elitek alone. Clinical TLS occurred in 3% of Elitek-treated patients, 3% of Elitek/oral allopurinol-treated patients, and 4% of oral allopurinol-treated patients.

Hypersensitivity reactions occurred in 4.3% of patients treated with Elitek alone and 1.1% of patients treated with the Elitek/oral allopurinol combination. Hypersensitivity reactions included arthralgia, injection site irritation, peripheral edema, and rash. The most common Grade 3/4 related adverse reactions regardless of relationship to study drug were sepsis (5.4% / 6.5% / 4.4%), hypophosphatemia (4.3% / 6.5% / 6.6%), anxiety (3.3% / 0% / 0%), abdominal pain (3.3% / 4.3% / 2.2%), hyperbilirubinemia (3.3% / 2.2% / 4.4%) and increased alanine aminotransferase (3.3% / 4.3% / 2.2%) in the Elitek, Elitek/oral allopurinol and oral allopurinol arms, respectively. Of note, all patients were receiving anti-cancer chemotherapy and/or biologic anti-cancer agents for their primary disease. The following serious adverse reactions occurred with a difference in incidence of greater than or equal to 2% in patients receiving Elitek compared to patients receiving oral allopurinol: pulmonary hemorrhage, respiratory failure, supraventricular arrhythmias, ischemic coronary artery disorders, and abdominal and gastrointestinal infections.

Based on the results of the above study, Elitek is now indicated at a daily dose of 0.20 mg/kg intravenously for up to 5 days for the initial management of plasma uric acid levels in adults with leukemia, lymphoma and solid tumors receiving anti-cancer therapy expected to result in tumor lysis syndrome and subsequent elevation of plasma uric acid.

About Elitek®

A recombinant urate oxidase enzyme, Elitek is the first recombinant uricolytic agent approved in the U.S. t
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Cervarix, GlaxoSmithKlines Cervical Cancer Vaccine
2. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
3. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
4. FDA Approves New Indication For Mirena(R) to Treat Heavy Menstrual Bleeding in IUD Users
5. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
6. Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
7. FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
8. FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
9. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
10. FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
11. FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2012)... 10, 2012 Cyberonics, Inc. (NASDAQ: ... the treatment and management of epilepsy, today announced it ... Conference on Monday, February 27, 2012, in New York. ... Financial Officer, will speak at 11:00 AM Eastern Time.  ... accessed by clicking on the Investor Relations link on ...
(Date:2/10/2012)... 10, 2012  Viztek, the digital radiology solution ... DR U-Arm at Edison Metuchen Orthopaedic Group (EMOG) ... surgeons and a psychiatrist with onsite x-ray and access ... in the same building. EMOG performs ... previously used two traditional analog x-ray rooms to ...
(Date:2/10/2012)... Children and adolescents with obstructive sleep apnea had ... life after treatment with positive airway pressure (PAP)—a ... stream of air through a mask into the ... when children didn,t fully adhere to the treatment," ... sleep specialist and director of the Sleep Center ...
Breaking Medicine Technology:Sleep Breathing Machine Shows Clear Benefits in Children with Sleep Apnea 2Sleep Breathing Machine Shows Clear Benefits in Children with Sleep Apnea 3Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday November 4 2009 After Close of U S Based Financial Markets 14652 1Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday November 4 2009 After Close of U S Based Financial Markets 14652 2Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 1Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 2Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 3Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 4Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 5Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 6Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 7NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 1NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 2NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 3
... Amicus Therapeutics (Nasdaq: FOLD ) today announced ... No. 7,501,439, titled "Tartrate Salt of Isofagomine and Methods of ... isofagomine, the active ingredient in the Company,s investigational drug Plicera(TM) ... disease. The patent will expire in 2027. John ...
... reduces abdominal pain and bloating CLEVELAND, March 24 ... Postgraduate Medicine found that a strain of probiotic bacteria, ... abdominal pain and bloating in subjects with irritable bowel ... percent of the U.S. population suffer from IBS, a condition ...
Other Medicine Technology:Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 2Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 3New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 2New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 3New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 4
(Date:2/10/2012)... the Faculty of Medicine & Dentistry at the University ... day be used to develop new therapies that target ... Mark Glover, his graduate student Zahra Havali-Shahriari and post-doctoral ... in cells when DNA is damaged. They solved the ... or PNKP. This allows them to see what is ...
(Date:2/10/2012)... One of the strongest known risk factors for spontaneous or ... 37th week of pregnancy, most often without a known cause ... group who would like to avoid this scenario in their ... not be the best strategy. A new study reported at ... between weight gain and the risk of repeat preterm birth. ...
(Date:2/10/2012)... Steven Reinberg HealthDay Reporter , , THURSDAY, Feb. ... three hours after using marijuana nearly doubles a driver,s ... review finds. The risk is especially high for ... less than that of people who drive drunk, Canadian ... risk of a crash at a higher level than ...
(Date:2/9/2012)... 10, 2012) In a study to be presented ... The Pregnancy Meeting , in Dallas, Texas, researchers will ... cells into the lateral ventricles of neonatal rats with ... cells can survive and migrate in the recipient,s brain. ... brain damage mimic brain injury in infants with very ...
(Date:2/9/2012)... obstructive sleep apnea had substantial improvements in attention, anxiety ... pressure (PAP)a nighttime therapy in which a machine delivers ... nose. , "The benefits occurred even when children ... Carole L. Marcus, M.D., a sleep specialist and director ... Philadelphia. The Sleep Center follows thousands of children and ...
Breaking Medicine News(10 mins):Health News:New understanding of DNA repair could eventually lead to cancer therapy 2Health News:To avoid early labor and delivery, weight and diet changes not the answer 2Health News:Pot Use Could Double Risk of Car Crash, Research Shows 2Health News:Pot Use Could Double Risk of Car Crash, Research Shows 3Health News:Pot Use Could Double Risk of Car Crash, Research Shows 4Health News:Neurologic improvement detected in rats receiving stem cell transplant 2Health News:Sleep breathing machine shows clear benefits in children with sleep apnea 2
... adults have a family history of end-stage renal disease ... of developing kidney disease// themselves, reports a study in ... ,"A family history of kidney disease is more ... risk of ESRD," comments Dr. William McClellan of Emory ...
... exercise is widely recognized to reduce the risk of ... the biological mechanisms behind the effect of exercise on ... exercise decreases inflammation, which reduces the risk of atherosclerosis ... most cases of heart disease. ,In a ...
... type of stem cells from the lungs of transplant patients ... in adult organs and are not derived from bone marrow, ... able to help with the rejection of donated organs and ... by University of Michigan Health System researchers is significant because ...
... ongoing research tries to find why cancer patients undergoing ... of appetite. //The study is also trying to investigate ... maintain a healthy diet during treatment. ,Researchers ... chemotherapy and radiation therapy on the senses report that ...
... a compound that regulates immune response in the ... allergies, if results from an animal study can ... and Philippe Eigenmann from the University Hospital of ... College Cork bioengineered a strain of Lactococcus lactis ...
... to the parents of Canada’s conjoined twins and to the ... //after days of several tests that the twins are growing ... Krista and Tatiana Hogan came into the world with their ... portray distinct sleep patterns, vision, hearing and responses to touch. ...
Other Medicine News:Health News:Ten Percent of Americans Has A Relative With Kidney Failure 2Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 2Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 3Health News:Special Diets Necessary for Those Undergoing Chemotherapy 2Health News:Lactococcus Strain may Offer End to Food Allergies 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: